TrialEuropean journal of nuclear medicine and molecular imaging2012

Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using 89Zr-ibritumomab tiuxetan and PET.

Saiyada N F Rizvi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.